TrialLancet (London, England)2024

Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.

Xu Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.